IndustryARC, in its latest report, predicts that Antiepileptic Drugs Market size is estimated to reach $21.4 billion by 2027, growing at a CAGR of 2.6% during the forecast period 2022-2027. Antiepileptic drugs are also delineated as anticonvulsants that are taken into account to treat seizure disorders which are commonly known as “Epilepsy.” This condition can set many complications like muscle stiffness, atypical sensations, abnormal behavior, and others in motion. The Antiepileptic Drugs Market report by IndustryARC covers complete analysis of the market, its major segments, growth factors, trends, drivers and challengers, key players and more.
Competitive Landscape:
The top 5 players in the Antiepileptic Drugs industry are –
1. Abbott Laboratories
2. Johnson & Johnson
3. Sanofi S.A.
4. Valeant Pharmaceuticals International
5. UCB Pharma
Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=15597
Segmental Analysis :
1. The Antiepileptic Drugs Market based on the drug type can be further segmented into the first generation (Mysoline, Zarontin, Carbatrol, Topamax, luminal, and others), second-generation (=Vimpat, Lyrica, Keppra, Aptiom, Banzel, Fycompa, and others), and third-generation drugs. The second-generation segment held the largest share in 2021. The growth is owing to higher effectiveness as compared to other categories of drugs.
2. The Antiepileptic Drugs Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 36% of the overall market in 2021. The growth in this segment is owing to the factors such as to-notch quality of healthcare infrastructure which is promoting better treatment and diagnosis rates.
3. The Antiepileptic Drugs Market based on distribution channels can be further segmented into offline channels (=hospital pharmacies, retail pharmacies, drug stores, and others), and online platforms. The offline segment held the largest share in 2021. The growth is owing to the full-fledge and all-encompassing nature of offline facilities as compared to online.
|
Report Coverage |
|
|
Report Attributes |
Details |
|
By Drug Type |
First generation,Second generation and Third generation drugs. |
|
By Form |
Dry (=tablets or pills) and Liquid. |
|
By Administered route |
Oral, Vein injections/Intravenous. |
|
By Distribution Channel |
Offline channels,Online Platforms. |
|
By Geography |
North America, Europe, Asia-Pacific, South America and Rest of World |
Get more detailed information about these segments in the report. Buy it here:
https://www.industryarc.com/reports/request-quote?id=15597
Market Drivers and Challenges :
1. Broadening cases of stress, depression, and accidents are Anticipated to Boost Product Demand: We all are living in a dynamic era where one has to put constant efforts in order to keep up with ever-growing competition otherwise, they may lag. In their pursuit of achieving something big or living a successful life people are constantly driving them into depression. This constant unrest is one of the biggest reasons behind mental disorders.
2. A massive push of companies in the development of novel third-generation drugs is Expected to Boost Product Demand: It should not come as a surprise that epileptic seizures are more common in the elderly population. Therefore, as the old-age population of the world is anticipated to touch the 1-2 billion mark within a few years various companies in their respective fields have stepped up their efforts to meet the rising demand and make profits.
3. Several health hitches accompanied by these drugs are Anticipated to Hamper Market Growth: In a few parts of the world talking about such neurological abnormalities is still considered taboo. Therefore, rather than revealing and undergoing a treatment people try to hide such complications which can strangle the growth in the respective market. Moreover, there are several health hitches of antiepileptic drugs that refrain people from consuming them.
Why IndustryARC?
IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. Get detailed report on preferred market as per your specific requirements and our research experts would customize the report for you.
Email: venkat@industryarc.com
USA: (+1) 614-588-8538, (+1) 815-656-4596
Similar Reports :
A. Brain Tumor Treatment Market
https://www.industryarc.com/Report/15949/brain-tumor-treatment-market.html
B. Rare Neurological Disease Treatment Market
https://www.industryarc.com/Research/rare-neurological-disease-treatment-market-508360
Media Contact
Company Name: IndustryARC
Contact Person: Mr. Venkat Reddy
Email: Send Email
Phone: (+1) 970-236-3677
Address:Madhapur
City: Hyderabad
Country: India
Website: https://www.industryarc.com/Report/15597/antiepileptic-drugs-market.html